2022
Randomized comparison of atrioventricular node re-entry tachycardia and atrial flutter catheter ablation with and without fluoroscopic guidance: ZeroFluoro study
LEHAR, František, Nandor SZEGEDI, Jakub HEJC, Jiří JEŽ, Filip SOUČEK et. al.Základní údaje
Originální název
Randomized comparison of atrioventricular node re-entry tachycardia and atrial flutter catheter ablation with and without fluoroscopic guidance: ZeroFluoro study
Autoři
LEHAR, František (203 Česká republika, domácí), Nandor SZEGEDI, Jakub HEJC, Jiří JEŽ (203 Česká republika, domácí), Filip SOUČEK (203 Česká republika, domácí), Tomáš KULÍK (203 Česká republika, domácí), Anna ŠIRŮČKOVÁ (203 Česká republika, domácí), Zoltan SALLO, Klaudia Vivien NAGY, Bela MERKELY, Laszlo GELLER a Zdeněk STÁREK (203 Česká republika, garant, domácí)
Vydání
EP Europace, Oxford, Oxford University Press, 2022, 1099-5129
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30201 Cardiac and Cardiovascular systems
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 6.100
Kód RIV
RIV/00216224:14110/22:00128480
Organizační jednotka
Lékařská fakulta
UT WoS
000841952900001
Klíčová slova anglicky
Catheter ablation of arrhythmias; Supraventricular tachycardias; Fluoroscopic guidance; Zero fluoro procedures; Radiation exposure; Effective dose; Three-dimensional electroanatomical mapping system
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 1. 2. 2023 13:10, Mgr. Tereza Miškechová
Anotace
V originále
Background Interventional cardiology procedures may expose patients and staff to considerable radiation doses. We aimed to assess whether exposure to ionizing radiation during catheter ablation of supraventricular tachycardia (SVT) can be completely avoided. Methods In this prospective randomized study, patients with SVT (atrioventricular re-entrant tachycardia n = 94, typical atrial flutter n = 29) were randomly assigned in a 1:1 ratio to catheter ablation with conventional fluoroscopic guidance (CF group) or with the EnSite Precision mapping system [zerofluoro (ZF) group]. Acute procedural parameters, increased stochastic risk of cancer incidence and 6-month follow-up data were assessed. Results Between May 2019 and August 2020, 123 patients were enrolled. Clinical parameters were comparable. Median procedural time was 60.0 and 58.0 min, median fluoroscopy time and estimated median effective dose were 240 s vs. 0 and 0.38 mSv vs. 0 and arrhythmia recurrence was 5% and 7.9% in the CF and ZF groups, respectively. The acute success rate was 98.4% in both groups. No procedure-related complications were reported. At an average age of 55.5 years and median radiation exposure of 0.38 mSv, the estimate of increased incidence was approximately 1 in 14 084. The estimated mortality rate was 1 per 17 857 exposed persons. Conclusions The procedural safety and efficacy of the zero-fluoroscopic approach are similar to those of conventional fluoroscopy-based ablation for atrioventricular nodal re-entrant tachycardia and atrial flutter. Under the assumption of low radiation dose, the excessive lifetime risk of malignancy in the CF group due to electrophysiology procedure is reasonably small, whilst totally reduced in zero fluoroscopy procedures.